GPB Passport icon GPB Passport icon Passport
GPB donate icon GPB donate icon Donate
Sign Up For Our Newsletter

News Articles: Food and Drug Administration

Food and Drug Administration Commissioner Stephen Hahn drew a hailstorm of criticism from scientists this week for mischaracterizing a study's findings in a way that hyped the benefits of convalescent plasma. He later apologized, but critics say the damage was done.

FDA's Hahn Apologizes For Overselling Plasma's Benefits As A COVID-19 Treatment

The Food and Drug Administration's chief said Sunday the therapy reduces deaths among COVID-19 patients by 35%. On Monday he apologized, acknowledging that statistic greatly exaggerates any benefit.

|
By:
  • Richard Harris